Download Mobile App

Video Library

Partner Sites

HospiMedica

World’s Smallest Heart Pump Maintains Blood Pressure and Flow During Stent Placement

New Ablation Technique Shows Promise for Hard-to-Treat Ventricular Tachycardia Heart Rhythms

New Technology Provides First-of-Its-Kind, Unobstructed View into Minimally Invasive Spine Surgery Procedures

Wearable Sweat Sensor Provides Continuous Monitoring for Health Conditions

World’s First Smart Knee Implant Optimizes Patient Monitoring and Recovery After Surgery

New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

Image: MagCore EDA - Automated NA Extraction and Smart PCR Setup (Photo courtesy of RBC Bioscience)

A new instrument launched at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo that combines DNA/RNA extraction and Smart PCR Setup provides a complete solution for lab workflow optimization.

At AACC 2022, RBC Bioscience Corp. (New Taipei City, Taiwan) released its new MagCore EDA which has three modes of operation: NA extraction, PCR setup and NA extraction with PCR setup. MagCore EDA presents a set of unique features such as HEPA filters, cooling plate for idling eluates, spectrophotometer for automatic OD measurements at the end of extraction, safety locks, that ensure the ease of use and safety of the system. The system has features such as PC USB control interface, 1-48 Samples, built-in cooler, HEPA filters, UV decontamination, auto barcode scanner, spectrophotometer, PCR assay setup and serial dilution, LIMS connectivity, and built-in program.

“With the capability of the NA extraction and PCR set up preparation as one operation the instrument provides massive benefits to its users,” said David Cho, CEO of RBC Bioscience Corp. “PCR zone is opened, so the machine can be used by anyone with any kits or reagents they are using, including in-house PCR preparations. Machine passed extensive testing targeting user experience, safety, durability, robustness of the system, pipetting precision and liquid level detection – it is an ultimate solution for most of the mDx users, no matter in research or in clinical market.”

Related Links:
RBC Bioscience Corp.